首页> 美国卫生研究院文献>Frontiers in Pharmacology >Anti-adipogenic Effects and Mechanisms of Ginsenoside Rg3 in Pre-adipocytes and Obese Mice
【2h】

Anti-adipogenic Effects and Mechanisms of Ginsenoside Rg3 in Pre-adipocytes and Obese Mice

机译:人参皂苷Rg3在前脂肪细胞和肥胖小鼠中的抗脂肪形成作用及其机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Red or black ginseng has been reported more powerful than white/fresh ginseng in dealing with various diseases/conditions including obesity. The major reason is that heating/steaming, the process of making red or black ginseng, produces large amount of bioactive compounds including ginsenoside Rg3 (Rg3), which are trace in fresh or white ginseng. In the present study, Rg3 was applied both in pre-adipocytes and obese mice to investigate the anti-adipogenic effects and relevant mechanisms. Our results show that Rg3 dose-dependently inhibited cell differentiation both in 3T3-L1 cells (30, 50, and 100 μM) and human primary pre-adipocytes (10, 20, and 30 μM). This inhibitory effect is accompanied by the attenuation of the expressions of adipogenic markers including peroxisome proliferator-activated receptor gamma (PPAR-γ), CCAAT/enhancer binding protein alpha (C/EBP-α), fatty acid synthase (FAS), fatty acid binding protein 4 (FABP4) and perilipin. Although dietary intake of Rg3 (0.1 mg Rg3/kg diet, 8 weeks) did not significantly affect body weight gain, fat pads and food intake as well as of PPAR-γ expression in fat tissues, we found that hepatic PPAR-γ and C/EBP-α protein expressions and hepatic glutathione reductase and glutathione S-transferase, two major antioxidants molecules were significantly reduced by Rg3. These results suggest that ginsenoside Rg3 may be a potential agent in reducing/preventing obesity.
机译:据报道,红色或黑色人参在治疗包括肥胖症在内的各种疾病/病症方面比白色/新鲜人参更有效。主要原因是加热/蒸煮(生产红色或黑色人参的过程)会产生大量生物活性化合物,其中包括人参皂甙Rg3(Rg3),它们存在于新鲜或白色人参中。在本研究中,Rg3应用于肥胖前脂肪细胞和肥胖小鼠中,以研究其抗脂肪形成作用及其相关机制。我们的结果表明,Rg3剂量依赖性地抑制3T3-L1细胞(30、50和100μM)和人原代前脂肪细胞(10、20和30μM)中的细胞分化。这种抑制作用伴随着成脂标记物表达的减弱,这些标记物包括过氧化物酶体增殖物激活受体γ(PPAR-γ),CCAAT /增强子结合蛋白α(C /EBP-α),脂肪酸合酶(FAS),脂肪酸结合蛋白4(FABP4)和周脂素。尽管饮食中摄入Rg3(0.1 mg Rg3 / kg饮食,8周)并未显着影响体重增加,脂肪垫和食物摄入以及脂肪组织中PPAR-γ的表达,但我们发现肝脏PPAR-γ和C Rg3显着降低了两种主要抗氧化剂分子的/EBP-α蛋白表达和肝谷胱甘肽还原酶和谷胱甘肽S-转移酶。这些结果表明人参皂苷Rg3可能是减少/预防肥胖的潜在药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号